Table 4.
Development of ERCP Pancreatitis in Stent and Control Groups
| EP (-) | EP (+) | Total | p | ||||
| n | % | n | % | n | % | 0.072 | |
| Stent | 16 | 100 | 0 | 0 | 16 | 100 | |
| Control | 22 | 78.6 | 6 | 21.4 | 28 | 100 | |
| Total | 38 | 86.4 | 6 | 13.6 | 44 | 100 | |
Development of ERCP Pancreatitis in Stent and Control Groups
| EP (-) | EP (+) | Total | p | ||||
| n | % | n | % | n | % | 0.072 | |
| Stent | 16 | 100 | 0 | 0 | 16 | 100 | |
| Control | 22 | 78.6 | 6 | 21.4 | 28 | 100 | |
| Total | 38 | 86.4 | 6 | 13.6 | 44 | 100 | |